IP Library Granted Patent US 10,434,044
Granted Patent B2
US 10,434,044 · App. 15/791,554 · Granted Oct 8, 2019

Buffered microencapsulated compositions and methods

Inventors: Mark A. Latta (Omaha, NE); Stephen M. Gross (Omaha, NE); William A. McHale (Collegeville, PA)
Assignee: Premier Dental Products Company
A61K8/11A61K6/0017A61K6/0067A61K6/0073A61K8/19A61K8/21A61K8/24A61K8/64A61K8/87A61K9/0056A61K9/5031A61K9/5089A61K33/06A61K33/16A61K33/44A61K47/02A61Q3/02A61Q5/02A61Q5/06A61Q5/12A61Q11/00A61Q19/00A61K2800/412
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,434,044
App. No.
15/791,554
Granted
Oct 8, 2019
Kind
B2
Abstract

A microcapsule composition comprising at least one polymer substantially disposed as a semi-permeable shell around a buffered solution and at least one therapeutic agent, wherein the therapeutic agent permeates the shell, and wherein the composition is suitable for delivery to a mammal. This invention also provides related compositions, products and methods.

Claims (13)

1. A product for treating or reducing the likelihood of caries, comprising a microcapsule composition comprised of a first plurality of microcapsules and a second plurality of microcapsules, said first plurality of microcapsules comprising an amphiphilic polyurethane polymer substantially disposed as a semi-permeable shell around a first buffered solution and at least a first therapeutic agent within said buffered solution in said first plurality of microcapsules wherein the therapeutic agent is an anti-caries, and said second plurality of microcapsules comprising an amphiphilic polyurethane polymer substantially disposed as a semi-permeable shell around a second buffered solution comprising a second therapeutic agent within said second buffered solution in said second plurality of microcapsules, wherein each of the first or second therapeutic agents permeate the shell, and wherein the product is suitable for delivery to a mammal, and wherein the microcapsules are prepared by an interfacial polymerization of a reverse emulsion.

2. The product of claim 1 , wherein the first buffered solution is selected from at least one of Ca(NO 3 )2, K 2 HPO 4 and NaF, wherein the shell is permeable to Ca(NO 3 )2, K 2 HPO 4 and NaF.

3. The product of claim 1 , wherein the second therapeutic agent causes tissue mineralization.

4. The product of claim 1 , wherein the first subset of microcapsules has a therapeutic agent release profile that differs from the therapeutic agent release profile of the second subset of microcapsules.

5. The product of claim 1 , wherein the buffered solution is an aqueous solution.

6. The product of claim 1 , wherein the buffered solution is a non-aqueous solution.

7. The product of claim 1 , wherein the second therapeutic agent, is selected from the group consisting of an antimicrobial agent, a tooth-whitening agent, an antibiotic, an anticoagulant, a remineralizing agent, an anti-caries agent, a desensitizing agent, and an anti-inflammatory agent.

8. The product of claim 1 , wherein the molecular weight of the polymer is from about 1,000 to about 20,000 g/mole.

9. The product of claim 1 , wherein the polymer is cross-linked.

10. The product of claim 1 , wherein each of a microcapsule of the first or second plurality of microcapsules has a diameter of from about 1 micron to about 3 mm.

11. The product of claim 1 in the form of a paste, a gel, a foam, a rinse, a dentifrice, a tooth whitening product, a breath freshener, an artificial saliva system, a varnish, a desensitizer, a dental restorative, a composite, an adhesive, a cement, a bioactive glass, a glass ionomer, a compomer, a giomer, a resin, a denture tooth, a denture base material, a root canal filler, a sealer, a chewing gum, a dental implant tissue regeneration material, a pulp capping material and a filling restorative.

12. The product of claim 1 further comprising an additive selected from the group consisting of preservatives, antitartar agents, anticalculus agents, antimicrobial agents, flavorings, sweeteners and dyes.

13. The product of claim 1 further comprising a pharmaceutically acceptable carrier.

Assignments (4)
SECURITY INTEREST Recorded Mar 27, 2025
From: PREMIER DENTAL PRODUCTS COMPANY, LLC
To: FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070650/0397 →
ENTITY CONVERSION Recorded Mar 17, 2025
From: PREMIER DENTAL PRODUCTS COMPANY
To: PREMIER DENTAL PRODUCTS COMPANY, LLC
Reel/Frame 070537/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2018
From: GROSS, STEPHEN M.; MCHALE, WILLIAM A.; LATTA, MARK A.
To: PREMIER DENTAL PRODUCTS COMPANY
Reel/Frame 046503/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2018
From: LATTA, MARK A.; GROSS, STEPHEN M.; MCHALE, WILLIAM A.
To: PREMIER DENTAL PRODUCTS COMPANY
Reel/Frame 045616/0069 →
Continuity (4)
Division 13619128 · Sep 14, 2012
Continuation In Part 12768696 · Apr 27, 2010
Provisional Application 61172939 · Apr 27, 2009
Related Publication 20180042826A1 · Feb 15, 2018